BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16407287)

  • 1. A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.
    Samino Y; López D; Guil S; Saveanu L; van Endert PM; Del Val M
    J Biol Chem; 2006 Mar; 281(10):6358-65. PubMed ID: 16407287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.
    Nakagawa Y; Takeshita T; Berzofsky JA; Takahashi H
    Immunology; 2000 Sep; 101(1):76-82. PubMed ID: 11012756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.
    Samino Y; Lopez D; Guil S; de León P; Del Val M
    J Biol Chem; 2004 Jan; 279(2):1151-60. PubMed ID: 14583622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.
    Blanchard N; Kanaseki T; Escobar H; Delebecque F; Nagarajan NA; Reyes-Vargas E; Crockett DK; Raulet DH; Delgado JC; Shastri N
    J Immunol; 2010 Mar; 184(6):3033-42. PubMed ID: 20173027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
    Oldstone MB; Lewicki H; Borrow P; Hudrisier D; Gairin JE
    J Virol; 1995 Dec; 69(12):7423-9. PubMed ID: 7494247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
    Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidases trimming MHC class I ligands.
    Weimershaus M; Evnouchidou I; Saveanu L; van Endert P
    Curr Opin Immunol; 2013 Feb; 25(1):90-6. PubMed ID: 23089230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.
    Infantes S; Samino Y; Lorente E; Jiménez M; García R; Del Val M; López D
    J Immunol; 2010 Apr; 184(7):3351-5. PubMed ID: 20200278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
    Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
    Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
    J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160.
    Shirai M; Kurokohchi K; Pendleton CD; Arichi T; Boyd LF; Takahashi H; Margulies DH; Berzofsky JA
    J Immunol; 1996 Nov; 157(10):4399-411. PubMed ID: 8906815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
    J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimming of antigenic peptides in an early secretory compartment.
    Snyder HL; Yewdell JW; Bennink JR
    J Exp Med; 1994 Dec; 180(6):2389-94. PubMed ID: 7964513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.
    Takahashi M; Nakagawa Y; Berzofsky JA; Takahashi H
    Int Immunol; 2001 Jan; 13(1):43-51. PubMed ID: 11133833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope.
    López D; Samino Y; Koszinowski UH; Del Val M
    J Immunol; 2001 Oct; 167(8):4238-44. PubMed ID: 11591745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
    Li L; Batliwala M; Bouvier M
    J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.